Intestinal ischemia and the gut-liver axis:: An in vitro model

被引:36
|
作者
Towfigh, S
Heisler, T
Rigberg, DA
Hines, OJ
Chu, J
McFadden, DW
Chandler, C [1 ]
机构
[1] Sepulveda Vet Adm Med Ctr, Dept Surg, N Hills, CA 91343 USA
[2] Univ Calif Los Angeles, Med Ctr, Dept Surg, Los Angeles, CA 90095 USA
关键词
ischemia; Kupffer cell; gut-liver axis; cytokine; tumor necrosis factor alpha; interleukin-6;
D O I
10.1006/jsre.1999.5767
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Sustained intestinal ischemic injury often leads to shock and multiorgan failure, mediated in part by a cytokine cascade. Animal models have also identified a central role of Kupffer cells in amplification of cytokines following intestinal ischemia, To better understand this gut-liver axis, we developed an in vitro model. Materials and methods. Kupffer cells were isolated from rat livers by arabinogalactan gradient ultracentrifugation and adherence purification, Cells were grown in RPMI medium in 5% CO2. Rat intestinal epithelial cells, IEC-6, were cultured under normoxic or anoxic (90% N-2, 10% CO2) conditions for 2, 12, and 24 h, Kupffer cells were then grown in the conditioned medium of the IEC-6 cultures. After 24 h, the medium was replaced with fresh medium. This final Kupffer cell supernatant was tested for tumor necrosis factor alpha and interleukin-6 production by ELISA. Trypan blue exclusion was performed to assess cell viability. Results. Intestinal and Kupffer cells remained viable during the experimental time. Production of both tumor necrosis factor alpha and interleukin-6 by Kupffer cells increased with increasing ischemia time of the intestinal cells. Conclusions, Consistent with animal studies of intestinal ischemia, this study found an increase in cytokine production by Kupffer cells following hypoxia of intestinal cells. This in vitro model offers a new tool to study the expression of cytokines, proteins, and messengers involved in the cascade of events that follow intestinal ischemia, (C) 2000 Academic Press.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 50 条
  • [31] Importance of the gut microbiota in the gut-liver axis in normal and liver disease
    Kotlyarov, Stanislav
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (06)
  • [32] Gut-liver axis: barriers and functional circuits
    Pabst, Oliver
    Hornef, Mathias W.
    Schaap, Frank G.
    Cerovic, Vuk
    Clavel, Thomas
    Bruns, Tony
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (07) : 447 - 461
  • [33] The Gut-Liver Axis in Primary Sclerosing Cholangitis
    Eksteen, Bertus
    CLINICS IN LIVER DISEASE, 2016, 20 (01) : 1 - +
  • [34] Gut-liver axis in health and disease Abstracts
    不详
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 1 (02) : 51 - 96
  • [35] Gut-liver axis signaling in portal hypertension
    Simbrunner, Benedikt
    Mandorfer, Mattias
    Trauner, Michael
    Reiberger, Thomas
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (39) : 5897 - 5917
  • [36] Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies
    Giordano, Debora Maria
    Pinto, Claudio
    Maroni, Luca
    Benedetti, Antonio
    Marzioni, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [37] Gut-liver on a chip toward an in vitro model of hepatic steatosis
    Lee, Seung Yeon
    Sung, Jong Hwan
    BIOTECHNOLOGY AND BIOENGINEERING, 2018, 115 (11) : 2817 - 2827
  • [38] Lipotoxicity and the gut-liver axis in NASH pathogenesis
    Marra, Fabio
    Svegliati-Baroni, Gianluca
    JOURNAL OF HEPATOLOGY, 2018, 68 (02) : 280 - 295
  • [39] Microbiota and Gut-Liver Axis: An Unbreakable Bond?
    Sivaprasadan, Saraswathy
    Anila, K. N.
    Nair, Krishnanunni
    Mallick, Shweta
    Biswas, Lalitha
    Valsan, Arun
    Praseedom, Raaj Kumar
    Nair, Bipin Kumar G.
    Sudhindran, Surendran
    CURRENT MICROBIOLOGY, 2024, 81 (07)
  • [40] Gut-liver axis in inflammatory bowel disease
    Egresi Anna
    Kovacs Agota
    Szilvas Agnes
    Blazovics Anna
    ORVOSI HETILAP, 2017, 158 (26) : 1014 - 1021